MedTrace Logo

Study of a Single Dose of PRS-060 Administered by Oral Inhalation or IV Infusion in Healthy Subjects

NCT03384290 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2020-11-16

No results posted yet for this study

Summary

A Dose Escalating Study of PRS-060 Administered by Oral Inhalation or IV Infusion in Healthy Subjects

Conditions

  • Healthy Subjects

Interventions

DRUG

PRS-060

Drug

DRUG

Placebo

PRS-060 Matching Placebo

Sponsors & Collaborators

  • Pieris Australia Pty Ltd

    lead INDUSTRY

Principal Investigators

  • Jason Lickliter, MBBS PhD · Nucleus Network

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-12-08
Primary Completion
2018-10-11
Completion
2018-10-11

Countries

  • Australia

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03384290 on ClinicalTrials.gov